126 related articles for article (PubMed ID: 9186463)
1. Surgical treatment and outcome for node-negative gastric cancer.
Maehara Y; Tomoda M; Tomisaki S; Ohmori M; Baba H; Akazawa K; Sugimachi K
Surgery; 1997 Jun; 121(6):633-9. PubMed ID: 9186463
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.
Deng J; Liang H; Sun D; Zhang R; Zhan H; Wang X
Can J Gastroenterol; 2008 Oct; 22(10):835-9. PubMed ID: 18925308
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time.
Maehara Y; Okuyama T; Moriguchi S; Orita H; Kusumoto H; Korenaga D; Sugimachi K
Cancer; 1992 Jul; 70(2):392-5. PubMed ID: 1617589
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis.
Yokota T; Ishiyama S; Saito T; Teshima S; Narushima Y; Murata K; Iwamoto K; Yashima R; Yamauchi H; Kikuchi S
Scand J Gastroenterol; 2004 Apr; 39(4):380-4. PubMed ID: 15125471
[TBL] [Abstract][Full Text] [Related]
7. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer.
Baba H; Maehara Y; Takeuchi H; Inutsuka S; Okuyama T; Adachi Y; Akazawa K; Sugimachi K
Surgery; 1995 Feb; 117(2):165-9. PubMed ID: 7846620
[TBL] [Abstract][Full Text] [Related]
8. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
9. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery.
Isozaki H; Okajima K; Kawashima Y; Yamada S; Nakata E; Nishimura J; Ichinona T
J Surg Oncol; 1993 Aug; 53(4):247-51. PubMed ID: 8341056
[TBL] [Abstract][Full Text] [Related]
12. Impact of splenectomy for lymph node dissection on long-term surgical outcome in gastric cancer.
Lee KY; Noh SH; Hyung WJ; Lee JH; Lah KH; Choi SH; Min JS
Ann Surg Oncol; 2001 Jun; 8(5):402-6. PubMed ID: 11407513
[TBL] [Abstract][Full Text] [Related]
13. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
[TBL] [Abstract][Full Text] [Related]
14. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.
Maehara Y; Kakeji Y; Oda S; Takahashi I; Akazawa K; Sugimachi K
Br J Cancer; 2000 Oct; 83(8):986-91. PubMed ID: 10993643
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of No.12 lymph node dissection for advanced gastric cancer].
You X; Wang Y; Li W; Zhao X; Cheng Z; Xu N; Huang C; Liu G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):283-288. PubMed ID: 28338161
[TBL] [Abstract][Full Text] [Related]
16. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
17. Significance of para-aortic lymph node dissection in advanced gastric cancer.
Kunisaki C; Shimada H; Yamaoka H; Wakasugi J; Takahashi M; Akiyama H; Nomura M; Moriwaki Y
Hepatogastroenterology; 1999; 46(28):2635-42. PubMed ID: 10522056
[TBL] [Abstract][Full Text] [Related]
18. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
19. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
20. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
